The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.

Journal of Cardiovascular and Thoracic Research is a premier open access journal published by Tabriz University of Medical Sciences & Health Services, focusing on the dynamic fields of cardiology and cardiovascular medicine. With an ISSN of 2008-5117 and E-ISSN 2008-6830, the journal provides a platform for innovative research and advances in cardiovascular and thoracic health, catering to a global audience of researchers, healthcare professionals, and students. Since its inception as an open access publication in 2010, the journal has established itself within the academic community, evidenced by its inclusion in Scopus and its category quartile ranking (Q3) in 2023. Located in Tabriz, Iran, the journal aims to disseminate high-quality studies that contribute to the understanding and treatment of cardiovascular diseases, thus enabling advancements in this critical field of medicine. With a Scopus rank of 248 out of 387 in the category of Cardiology and Cardiovascular Medicine, the Journal of Cardiovascular and Thoracic Research is dedicated to fostering collaboration and dialogue among researchers and practitioners, promoting a deeper understanding of cardiovascular and thoracic health.

JACC: Cardiovascular Interventions is a premier journal dedicated to the field of cardiology and cardiovascular medicine, published by Elsevier Science Inc. This esteemed journal, with an ISSN of 1936-8798 and an E-ISSN of 1876-7605, has established itself as a leading platform for disseminating cutting-edge research and advancements from 2008 to the present, and is projected to continue until 2024. Recognized for its rigorous peer-review process and high-quality content, JACC: Cardiovascular Interventions holds a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine as well as a Q1 ranking in the broader category of Medicine (Miscellaneous) as of 2023. With a Scopus rank of #25 out of 387 in its field, placing it in the 93rd percentile, the journal is a vital resource for researchers, healthcare professionals, and students alike. Although it does not currently offer open access, its essential contributions to the medical community underscore its importance in advancing cardiovascular intervention knowledge and practice.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

The Journal of Cardiovascular Computed Tomography, published by Elsevier Science Inc, is a premier international journal dedicated to the field of cardiovascular imaging and technology. With a strong impact factor, it serves as a pivotal platform for disseminating cutting-edge research and advancements from 2007 to 2024, specifically within the realms of cardiology and radiology. The journal holds a distinguished Q1 ranking in both Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, reflecting its influential role in shaping clinical and academic discourse in these fields. Notably, the journal boasts impressive Scopus rankings, placing it in the top decile of its categories, highlighting its high-quality publications and significant contribution to the scientific community. Although it does not operate under an open access model, it ensures robust accessibility for researchers, professionals, and students eager to stay informed about the latest innovations and studies in cardiovascular computed tomography. The Journal of Cardiovascular Computed Tomography is essential for anyone involved in cardiovascular research, offering valuable insights and fostering collaborations across disciplines.

Cardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Cardiovascular Intervention and Therapeutics, published by SPRINGER JAPAN KK, stands as a prominent journal within the fields of cardiology and cardiovascular medicine, reflecting its commitment to disseminating groundbreaking research and clinical advances. With an impressive Q2 ranking in Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous), and a Q1 ranking in Radiology, Nuclear Medicine and Imaging, this journal employs rigorous peer-review processes to ensure the quality and relevance of its content. Catering to a diverse audience of researchers, clinicians, and students, the journal aims to foster innovation and enhance understanding through the publication of original research, reviews, and clinical studies focused on cardiovascular interventions and therapies. Spanning over a decade of evolution from 2010 to 2024, Cardiovascular Intervention and Therapeutics continues to be a vital resource for advancing knowledge and practice in the cardiovascular field. Explore the latest advancements and insights that this esteemed journal has to offer, and contribute to the ongoing dialogue that shapes modern cardiovascular medicine.